We have recently shown that a human CD4+ T cell line (CEM-SS) acquires the permissiveness to M-tropic strains and primary isolates of HIV-1 after transplantation into SCID mice. This permissiveness was associated with the acquisition of a memory (CD45RO+) phenotype as well as of a functional CCR5 coreceptor. In this study, we have used this model for investigating in vivo the relationships between HIV-1 infection, apoptosis and T cell differentiation. When an in vivo HIV-1 infection was performed, the CEM cell tumors grew to a lower extent than the uninfected controls. CEM cells explanted from uninfected SCID mice (ex vivo CEM) underwent a significant level of spontaneous apoptosis and proved to be CD45RO+, Fas+ and Fas-L+, while Bcl-2 expression was significantly reduced as compared to the parental cells. Acute HIV-1 infection markedly increased apoptosis of uninfected ex vivo CEM cells, through a Fas/Fas-L-mediated autocrine suicide/ fratricide, while parental cells did not undergo apoptosis following viral infection. The susceptibility to apoptosis of ex vivo CEM cells infected with the NSI strain of HIV-1, was progressively lost during culture, in parallel with the loss of Fas-L and marked changes in the Bcl-2 cellular distribution. On the whole, these results are strongly reminiscent of a series of events possibly occurring during HIV-1 infection. After an initial depletion of bystander CD4+ memory T cells during acute infection, latently or chronically infected CD4+ T lymphocytes are progressively selected and are protected against spontaneous apoptosis through the development of an efficient survival program. Studies with human cells passaged into SCID mice may offer new opportunities for an in vivo investigation of the mechanisms involved in HIV-1 infection and CD4+ T cell depletion. Cell Death and Differentiation (2000) 7, 37 ± 47.
Introduction
The central problem of HIV-1 pathogenesis is the decline of CD4+ T lymphocytes, which precedes the progression from asymptomatic infection to the acquired immunodeficiency syndrome (AIDS). Mechanisms underlying CD4+ T cell depletion in AIDS patients still remain poorly understood. 1, 2 Progress in this area has been hampered by the problems in reconciling the results obtained in studies using in vitro cell systems with the events occurring under in vivo conditions and, possibly, with those observed in HIV-1 infected patients. For instance, some isolates of HIV-1 recovered from patients with CD4+ T cell depletion show no cytopathic effect on cultured human T cells, suggesting that HIV-1 infection may lead to dysfunction and eventual loss of CD4+ T cells by indirect mechanisms that do not require virus infection of the target cells. 3 Recent data highly support the hypothesis that one of the major causes of CD4+ T cell depletion, both in the peripheral blood and in the lymph nodes of AIDS patients, is the virus-mediated induction of apoptosis of bystander CD4+ T cells. 4 ± 7 Of interest, various reports have shown that CD4+ memory T cells (CD45RO+) may represent the major target for both HIV-1 infection and HIV-1-induced apoptosis. 8 ± 11 However, mechanisms responsible for these phenomena are still unknown.
Human-severe combined immunodeficient (SCID) mouse xenografts represent unique and practical in vivo models to study the early events triggered by the interaction of HIV-1 with the human immune system. 12 ± 18 In particular, the interactions between human lymphoid cells and the SCID mouse environment occurring in these models can lead to a marked activation/differentiation of the immune cells.
cells. 22 In the present study, we first investigated in vivo the effects of various HIV-1 strains on the growth of CEM cells in SCID mice. Moreover, we characterized the apoptotic phenotype of CEM cells obtained from SCID mice tumors (ex vivo CEM cells) and the effects of HIV-1 infection. We found that transplantation of CEM cells in SCID mice induced apoptotic behavior in these cells and that this newly acquired property was strongly associated with the expression of the CD45RO+ phenotype. HIV-1 infection markedly increased the apoptosis of bystander CEM cells through a massive Fasmediated autocrine suicide/fratricide. After this early phase, T-tropic strains of HIV-1 induced cytopathic effect, while Mtropic strains led to a low level of chronic infection in CEM cells, which gained resistance to spontaneous apoptosis through the development of an efficient survival program. On the whole, these data, obtained in a human-SCID mouse model, recapitulate a sequence of events that may occur in the natural history of AIDS, such as CD4+ T cell depletion and the development of latently infected cells. 23, 24 Thus, studies with human cells passaged in SCID mice may offer new opportunities for in vivo investigating the mechanisms underlying HIV-1 infection and CD4+ T cell depletion.
Results

Impairment of CEM cells tumor growth and enhanced apoptosis of CEM cells by in vivo acute HIV-1 infection in SCID mice
We performed an acute infection with the SF162 or the IIIB HIV-1 strains contemporaneously to the CEM cells subcutaneous (s.c.) injection in SCID mice. Consistently with a recent finding, 22 CEM-SCID mouse xenografts were highly infected with both the HIV-1 strains used, while the parental CEM cells were in vitro infectable exclusively with the T-tropic strain of HIV (data not shown). This was due to a significant upregulation of a functional CCR5 on CEM cells that was crucial in rendering these cells permissive to the M-tropic strain of HIV-1, SF162. 22 As shown in Figure 1A , infection with both HIV-1 strains resulted in a marked delay in the growth of CEM cell s.c. tumors in SCID mice, as compared to the uninfected tumors. To assess the nature of this virus-induced in vivo delay of CEM cell tumor growth, we compared the levels of spontaneous apoptosis, by flow cytometric analysis of TUNEL reaction, in single cell preparations of CEM cells collected from HIV-1 infected and uninfected s.c. tumors (ex vivo CEM cells), when the tumors reached 1 cm in diameter. The results showed that uninfected ex vivo CEM cells exhibited remarkable levels of spontaneous apoptosis (30 ± 40%). However, higher levels of apoptosis (60 ± 75%) were observed in ex vivo CEM cells from HIV-1-infected tumors ( Figure 1B) . Notably, histological analysis showed that both infected and uninfected CEM tumors were highly vascolarized and poorly necrotic (data not shown).
CEM cells obtained from SCID mice exhibit an apoptotic phenotype
This data prompted us to characterize the phenotype of uninfected and HIV-1-infected ex vivo CEM cells, as compared to the parental cell line. We firstly analyzed the expression of CD45RO, CD45RA, Fas, Fas-L, Bcl-2, Bcl-x L and Bax, in uninfected ex vivo and parental CEM cells. Ex vivo and parental CEM cells did not show major differences in terms of T phenotypic markers, in that both cell types were CD4+, weakly CD3+, CD87 and CD147 (data not shown). Consistently with a previous report, 22 FACS analysis showed that ex vivo CEM had become CD45RO+, while parental CEM cells were CD45RO7 (data not shown). FACS analysis showed a significant induction of Fas-L expression and marked decrease of Bcl- Figure 2A) . The bcl2 protein level was also investigated by Western blot analysis. Consistently with the results of the flow cytometric analysis, the experiments showed significant reduction of bcl2 protein in ex vivo CEM cells as compared to the parental cells ( Figure 2B ). Densitometric analysis showed that there was a twofold increase of the bcl2 content in parental CEM cells with respect to ex vivo CEM cells. Consistently with the protein expression, RT ± PCR analysis showed lower level of bcl2 and higher level of FasL transcripts in ex vivo CEM cells, while no differences in the expression of Bax and Bcl-x L were observed ( Figure 2C ). Taken together, these data indicated that the phenotype of ex vivo CEM cells markedly differed from that of parental cells. This could be the result of either a progressive differentiation of CEM cells due to the stimuli present in the mouse environment or an expansion of a very small fraction of CEM cells (expressing the CD45RO phenotype, high level of Fas-L and low level of Bcl-2) in SCID mice. This hypothesis appears unlikely in the view of the fact that CD45RO and Fas-L are not expressed in parental CEM cells.
In examining the phenotype of HIV-1 infected ex vivo CEM cells, we found that the percentage of Fas-L+ cells was markedly increased as compared to the uninfected cells ( Figure 2D ), while Fas, Bcl-2, Bcl-x L and Bax mRNA expression did not differ between infected and uninfected ex vivo CEM cells (data not shown).
Mechanisms underlying HIV-1-induced apoptosis of ex vivo CEM cells
Then we investigated whether a Fas-mediated mechanism was involved in the in vivo HIV-1-induced apoptosis of CEM cells. We first explored the ability of both IIIB and SF162 HIV-1 strains to induce apoptosis of ex vivo CEM cells as compared to the parental cells. We observed that, at 48 h after virus challenge, both IIIB and SF162 induced a marked increase in the percentage of apoptotic cells as compared to the uninfected ex vivo CEM cells, while the parental CEM cells did not undergo apoptosis either spontaneously or after HIV-1 challenge ( Figure 3A ). Of interest, the values obtained with the acute infection of ex vivo CEM cells in culture condition were comparable to those observed in CEM cells collected from the s.c. tumors infected in vivo (shown in Figure 1B ).
The marked upregulation of Fas-L induced by HIV-1 infection (see Figure 2D ) strongly suggested that a Fasmediated mechanism was involved in the viral-induced apoptosis of ex vivo CEM cells. Thus, we firstly assessed the FasL expression on ex vivo CEM cells at 48 h after virus challenge, as compared to uninfected ex vivo and parental CEM cells. The results clearly showed that HIV-1 Figure 4C) . Furthermore, the apoptotic cells highly outnumbered the HIV-infected cells (70 ± 80% versus 5 ± 10%) ( Table 1) . Double staining experiments using flow cytometry or immunocytochemistry showed that the vast majority of Fas-L+ CEM cells were also Fas+ (data not shown).
Low level chronic infection leads to resistance to spontaneous apoptosis
We then observed the behavior of uninfected and HIV-infected ex vivo CEM cells maintained in culture conditions. Of interest, the effects of the IIIB (T-tropic) strain of HIV-1 on ex vivo CEM cells highly differed from that of the SF162 (M-tropic) strain. In fact, the IIIB strain induced a massive cytopathic effect in ex vivo CEM cell cultures 8 ± 10 days after in vitro infection, while the infection with SF162 HIV-1 strain did not induce in ex vivo CEM cell cultures cytopathic effect up to 30 days after infection (data not shown). Thus, we studied the apoptotic behavior of ex vivo CEM cells infected with the SF162 strain of HIV and maintained in culture conditions for 30 days, as compared to the ex vivo uninfected cells. The results firstly showed that ex Figure  5 ). To further confirm these data we cloned SF162-infected ex vivo CEM cells, obtaining infected and uninfected clones. The results showed that all the SF162-infected clones exhibited levels of spontaneous apoptosis significantly lower than the uninfected clones (8 ± 12% versus 19 ± 25% respectively), suggesting that chronic infection with a M-tropic strain of HIV-1 induced an anti-apoptotic state in infected ex vivo CEM cells. To further explore this issue, we evaluated the expression of the anti-apoptotic complex Bcl-2/Bcl-x L /Bax in uninfected and SF162-infected ex vivo CEM cells. The RT ± PCR analysis showed that there were no differences in the expression of Bcl-2, Bcl-x L and Bax mRNA between infected and uninfected ex vivo CEM cells and between infected and uninfected ex vivo CEM cells clones (data not shown). Flow cytometric analysis showed only a slight but significant increase in the percentage of Bcl-2+ cells in the SF162-infected ex vivo CEM cells, as compared to the uninfected cells ( Figure 6A ). However, the most impressive differences were detected by the in situ immunocytochemical analysis. In fact, the distribution of Bcl-2 highly differed between infected and uninfected cells. Ninety to 95% of SF162-infected cells showed an intense and diffuse cytoplasmic staining while virtually all the uninfected ex vivo CEM cells showed a highly localized pre-Golgi/perinuclear staining for Bcl-2 ( Figure 6B, upper panel) . Notably, the mitochondrial distribution did not differ between infected and uninfected cells ( Figure 6B , lower panel). Both flow cytometry and immunocytochemistry showed that infected cells expressed Fas-L at lower level than uninfected cells at this time, while Fas expression did not differ between infected and uninfected cells (data not shown). Notably, either HIV-1-infected ex vivo CEM cells or clones were reinoculated s.c. in SCID mice resulting in the development of highly productive (500+150 pg/ml p24 serum levels) tumors within 20 ± 30 days (data not shown), suggesting that in vivo or ex vivo selection of mutants with defective viruses did not occur in our experiments.
Discussion
The initial observation, which led to the ensemble of studies reported in this article, consisted in a marked delay in the growth of CEM s. (ii) HIV-1-induced apoptosis may be Fas-mediated 28 ± 36 and occurs predominantly in bystander cells. 5, 7, 35 Notably, given the specific features of this model, the HIV-1-induced Fasmediated apoptosis of uninfected cells occurs in a homotypic system of CD4+ T cells, suggesting that HIV-1 infection may trigger an autocrine suicide of CD4+ T lymphocytes without the participation of Fas-L expressing macrophages or CTL. 37 The possibility that apoptosis can occur through a Fas/Fas-Lmediated autocrine suicide has been proposed in lymphocyte 38 ± 40 and in other cell systems. 41, 42 Here we show that the in vivo acquired pathway of spontaneous apoptosis is associated with the expression of the memory (CD45RO+) phenotype on CEM cells. This is consistent with some reports showing that CD4+ memory T cells are generally more susceptible to apoptosis than naive T cells .43,44 Even though the role of memory T cells in CD4+ T cell depletion is controversial, 45 it is of interest to mention that some in vitro studies have shown that memory T cells are depleted by apoptosis more rapidly than naive T cells following HIV infection.
11,46 ± 48 Of interest, some body districts, such as intestinal mucosa, are particularly rich in CD4+ memory T cells and a consistent rate of Fas-mediated spontaneous apoptosis normally occurs in these districts. 49 We have recently shown that human intestinal CD4+ T cells are naturally permissive to a long lasting HIV-1 infection, which is highly related to the memory phenotype, as well as to the expression of HIV-1 coreceptors and to a baseline state of activation. 50 Notably, it has been reported that loss of CD4+ T cells in intestinal mucosa precedes the appearance of CD4+ T cell depletion in the peripheral blood of asymptomatic HIV infected patients. 51 Taking into consideration all these findings, it is conceivable that activated memory CD4+ T cells are the preferential target for both HIV-1 infection and apoptosis-mediated CD4+ T lymphocyte depletion in AIDS patients.
In the present study, we have also explored the longterm effects of HIV-1 on ex vivo CEM cells by maintaining infected cells in culture for 20 ± 30 days. The results have revealed a scenario of events dramatically different from that of the first 2 days post-infection. First, the T-tropic strain of HIV-1 induced a massive cytopathic effect in ex vivo CEM cells within the first 7 ± 10 days of culture. The cytopathic effect induced by T-tropic strains of HIV-1 is a well known phenomenon due to the formation of enormous syncytia through a continuous virus-induced cell-to-cell-tosyncytia fusion. 25 In contrast, the M-tropic strains of HIV did not induce any cytopathic effect, thus enabling us to investigate the effect of long lasting HIV-1 infection on apoptosis. Our results showed that: (i) the rate of spontaneous apoptosis progressively declined during time in culture, reaching values significantly lower than those of uninfected cells at 30 days of culture; (ii) the decrease of spontaneous apoptosis was associated with increased levels and diffuse cytoplasmic distribution of Bcl-2, as well as with lower levels of Fas-L, in infected ex vivo CEM cells as compared to the uninfected counterparts. It is well established that Bcl-2 protects cells from apoptosis. 52 However, the precise subcellular localization of bcl2 and its importance in the modulation of programmed cell death are both unresolved problems. Particularly, bcl2 has been identified at the inner 53 and the outer 54,55 mitochondrial membrane, the endoplasmic reticulum, 56,57 the nuclear membrane 54, 57 and close to the nuclei. 58 Variation in the cellular distribution of bcl2 protein is associated with different susceptibility to apoptosis. 58 Consistently with our data, resistance to apoptotic cell death is associated with a wide distribution of Bcl-2 within the cell, while the distribution of Bcl-2 to the perinuclear area is associated with an increased susceptibility to spontaneous apoptosis. 58 The subcellular distribution of Bcl-2 is considered to be a crucial event in allowing interactions with the other apoptosis regulatory proteins (e.g. Bax). Thus, the wider
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Thus, these results appear to be consistent with the hypothesis that HIV-1 may in vivo prevent apoptosis through Bcl-2 mediated mechanisms until high levels of virus are produced. In this regard, it is worth mentioning that small amounts of some HIV-1-proteins have been shown to prevent or delay death of infected cells through various antiapoptotic mechanisms. 2 As an example, low levels of endogenous expression of HIV-1 vpr can protect CD4+ T cells from apoptotic stimuli (including Fas pathway) through upregulation of Bcl-2. 59 Moreover, our results suggest that a bcl2-mediated mechanism may render CD4+ T cells particularly susceptible to HIV-1-mediated CD4+ T cell death via a Fas pathway. 60 In conclusion, our results, obtained in a model of SCID mice transplanted with CEM cells, are strongly reminiscent of a series of events possibly occurring in HIV-1 infected individuals. Particularly, our data indicate that an acute HIV-1 infection can induce a rapid CD4+ T lymphocyte depletion through a massive Fas-mediated autocrine suicide of differentiated memory CD4+ T cells, infecting a relative low number of lymphocytes. Following this dramatic scenario, CD4+ T lymphocytes infected with M-tropic strains of HIV-1, that do not induce cytopathic effect and predominate in the early phases of AIDS, 61 undergo a chronic infection becoming resistant to apoptosis through the development of an efficient survival program. Notably, the dynamics of CD4+ T cell differentiation and cell phenotype, possibly shaped by the cytokine environment, 62 may continuously change the CD4+ T cell permissiveness to HIV-1 strains which use CCR5 or CXCR4 as coreceptors. Thus, on one hand, HIV-1 may induce a massive Fas-mediated autocrine suicide/fratricide of uninfected CD4+ memory T cells during acute infection. On the other hand, HIV may inhibit or at least delay spontaneous apoptosis in chronically infected CD4+ T cells allowing a long lasting viral production. These cells may constitute a pool of latently infected CD4+ T cells that are rapidly established during primary infection 23 and are resistant to highly active antiretroviral therapy. 24 Lastly, these data emphasize the usefulness and versatility of human-SCID mouse models in investigating in vivo the relationships between T cell differentiation, HIV-1 infection and the mechanisms underlying CD4+ T cell depletion.
Materials and Methods
Growth of CEM cell-tumors in SCID mice and in vivo HIV-1 infection CB.17 SCID/SCID female mice (Charles River, Milan, Italy) were used at 4 ± 5 weeks of age and were kept under specific pathogen-free conditions. SCID mice were housed in microisolator cages and all food, water and bedding were autoclaved prior to use. The animal studies were performed in biosafety level three facility. Mice were injected subcutaneously (s.c.) in the shoulder with 20610 6 uninfected CEM cells 63 resuspended in 0.2 ml RPMI 1640 medium. The two major diameters of each tumor nodule were measured by callipers and the mean tumor diameter was calculated for each tumor. To deplete animals of some residual reactivity, SCID mice were injected i.p. with 0.2 ml of a monoclonal anti-mouse granulocyte antibody (RB6-8C5 hybridoma), 1 day before, 3 and 7 days after cell injection, as previously described. 63 The in vivo HIV infection of CEM-SCID mice was performed with a simultaneous s.c. injection of 20610 6 uninfected CEM cells with 10 6 TCID 50 cell-free virus. The viral strains used in these experiments were: HIV-1 IIIB and HIV-1 SF162 . In all conditions, the HIV-infected chimeras were sacrificed when the tumors reached 20 ± 25 mm mean diameter and analyzed for the virus replication at the tumor site and p24 antigenemia.
Detection of viral infection
At sacrifice, the CEM cell tumors were excised. To obtain single cell suspension tumors were carefully minced, mechanically disrupted with the blunt end of a 5-ml syringe plug and filtered. The single cell suspensions were washed twice in RPMI 1640 medium. Cell suspensions underwent: (i) HIV-1 DNA-PCR as previously described; 19 (ii) HIV-1 RT ± PCR, using specific primers which detect all viral RNAs, as reported elsewhere; 64 (iii) FACS analysis for human cells markers and apoptosis. Sera of infected animals were tested for HIV p24 antigen by an antigen capture enzyme-linked immunosorbent assay (Dupont, B-1130 Bruxelles, Belgium).
Cell culture and in vitro HIV-1 infection
Parental CEM cells (ATCC, Rockville, MD, USA) as well as CEM cells collected from s.c. tumors of SCID mice (ex vivo CEM cells) were cultured in RPMI 1640 medium supplemented with 10% heatinactivated fetal calf serum. Cells were seeded at 2610 5 /ml and passaged every 3 days. For in vitro HIV-1 infection cells were pelleted and incubated with the virus inoculum at 0.1 M.O.I. for 1 h at 378C, washed three times and cultured in complete medium. The virus stocks were derived from clarified culture medium of PHA-stimulated HIV-1-infected PBMC, frozen at 71408C. Titers were determined by standard end-point dilution methods. The virus strains used in these experiments were: HIV-1 IIIB , HIV-1 SF162 .
Cell cloning
CEM cells obtained from subcutaneous tumors were exposed to HIV-1 SF162 virus strain at 1 M.O.I. for 1 h at 378C, then washed extensively, and seeded in complete medium at a concentration of 0.5 cell/well in a 96-microwell cell culture plate. After 2 weeks pure clones were screened for virus infection by PCR. Infected as well as uninfected clones were propagated for further analyses as described.
Flow cytometry and apoptosis detection
CEM cells were washed twice with phosphate-buffered saline and stained for 30 min with the appropriate monoclonal antibody at 48C. The monoclonal antibodies used were anti-CD45RA FITC, anti-CD45RO PE (Becton Dickinson, Mountain View, San Diego, CA, USA), anti-FAS PE (Becton Dickinson, San Diego, CA, USA), anti-FAS-L (NOK-1, Pharmingen, CA, USA), anti-Bcl-2 (Neomarkers, Fremont, CA, USA). An anti-mouse IgG mAb PE (SIGMA) was used for indirect staining. Seventy per cent ethanol treatment was used to permeabilize cells before staining for Bcl-2. After staining cells were fixed with 2% paraformaldehyde and analyzed on a FACSORT cytometer (Becton Dickinson) equipped with a 488 nm argon laser. Data were recorded and analyzed by using LYSIS II software (Becton Dickinson). The analysis was performed by gating ex vivo CEM cells using forward and side scatter characteristics, to avoid SCID mouse cell contamination.
Apoptotic cells were detected by labeling DNA strand breaks with FITC-dUTP by terminal transferase (TUNEL reaction) (`In situ cell death detection kit', Boehringer Mannheim). Briefly 10 6 cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, 0.1% sodium cytrate and labeled at 378C for 60 min with TUNEL reaction mixture as recommended by the manufacturer. Apoptosis was evaluated directly by flow cytometry.
Fas blocking
Ex vivo CEM cells were infected with HIV-1 IIIB or HIV-1 SF162 strains in the absence or in the presence of an anti-Fas ZB4 neutralizing mAb (10 mg/ml) (UBI, NY, USA). Apoptosis was evaluated by FACS analysis 48 h postinfection.
RT ± PCR for apoptotic regulating genes mRNA for human pro-apoptotic and anti-apoptotic genes (Fas, Fas-L, Bcl-2, Bax, Bcl-x L ) were detected in CEM cells by RT ± PCR as previously described 19 with specific primer pairs: Fas-L 5' CAGCTCTTCCACCTACAGAAGGAG, 3' CAGAGAGAGCTCAGA-TACGTTGAC; primers specific for Fas, Bcl-2, Bax, Bcl-x L are reported elsewhere. 66 ± 69 The samples were amplified for 30 ± 35 cycles at the following conditions: 948C 40 s, 628C 40 s, 728 40 s. b 2 -microglobulin RT ± PCR 19 was run in parallel to normalize the levels of human RNA in all the samples.
Immunocytochemistry
Cell suspensions from the tumors were spun onto glass slides (Shandon, Cheshire, UK) or attached to L-polylysine-covered glass chamber slides (Labtek Naperville, IL, USA), 70 and stained by immunocytochemistry for HIV-p55/p18 (anti-HIV-p55/p18 IgG1, clone 11H9, from Medical Research Council AIDS Reagent Project, London, UK), Fas (Pierce, Rockford, IL, USA), Fas-L (Pharmigen, San Diego, CA, USA), Bcl-2 (Biomeda, Foster City, CA, USA), mitochondria (Chemicon, CA, USA) and TUNEL reaction (`In situ cell death detection kit' Boehringer Mannheim), 71 using the alkaline phosphatase anti-alkaline phosphatase (APAAP) (Dako, Denmark) method or the peroxidase-anti-peroxidase (PAP) (Dako, Denmark) method, in single and double staining, as appropriate. 70 
